Literature DB >> 24051907

Recommendations for the management and treatment of psoriatic arthritis.

Sueli Carneiro, Valderílio Feijó Azevedo, Rubens Bonfiglioli, Roberto Ranza, Célio Roberto Gonçalves, Mauro Keiserman, Eduardo de Souza Meirelles, Marcelo de Medeiros Pinheiro, Antonio Carlos Ximenes, Wanderley Bernardo, Percival Degrava Sampaio-Barros.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24051907

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN： 0482-5004


× No keyword cloud information.
  7 in total

Review 1.  Advances in rheumatology practice in Brazil.

Authors:  Francisco Airton Castro Rocha; Joaquim Ivo Vasques Dantas Landim; Leila Nascimento da Rocha
Journal:  Rheumatol Int       Date:  2018-12-01       Impact factor: 2.631

Review 2.  Seronegative arthritis in Latin America: a current review.

Authors:  Carla Gonçalves Schain Saad; Célio Roberto Gonçalves; Percival D Sampaio-Barros
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

Review 3.  Psoriatic arthritis: Epidemiology, diagnosis, and treatment.

Authors:  Jung-Tai Liu; Horng-Ming Yeh; Shyun-Yeu Liu; Kow-Tong Chen
Journal:  World J Orthop       Date:  2014-09-18

4.  Medication persistence for psoriatic arthritis in a Brazilian real-world setting.

Authors:  Michael Ruberson Ribeiro da Silva; Jéssica Barreto Ribeiro Dos Santos; Alessandra Maciel Almeida; Alexander Itria; Adriana Maria Kakehasi; Juliana Alvares Teodoro; Francisco de Assis Acurcio
Journal:  Future Sci OA       Date:  2019-01-18

5.  Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.

Authors:  Iain B McInnes; Philip J Mease; Christopher T Ritchlin; Proton Rahman; Alice B Gottlieb; Bruce Kirkham; Radhika Kajekar; Eumorphia-Maria Delicha; Luminita Pricop; Shephard Mpofu
Journal:  Rheumatology (Oxford)       Date:  2017-11-01       Impact factor: 7.580

6.  Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3).

Authors:  Peter Nash; Philip J Mease; Iain B McInnes; Proton Rahman; Christopher T Ritchlin; Ricardo Blanco; Eva Dokoupilova; Mats Andersson; Radhika Kajekar; Shephard Mpofu; Luminita Pricop
Journal:  Arthritis Res Ther       Date:  2018-03-15       Impact factor: 5.156

7.  Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry.

Authors:  Proton Rahman; Regan Arendse; Majed Khraishi; Dalton Sholter; Maqbool Sheriff; Emmanouil Rampakakis; Allen J Lehman; Francois Nantel
Journal:  BMJ Open       Date:  2020-08-13       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.